Remedent, Inc. REMI
OTC PK
| 03/31/2021 | |||||
|---|---|---|---|---|---|
| Revenue | 3.47% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 3.47% | ||||
| Cost of Revenue | 1.16% | ||||
| Gross Profit | 4.28% | ||||
| SG&A Expenses | 123.69% | ||||
| Depreciation & Amortization | -34.74% | ||||
| Other Operating Expenses | 17.54% | ||||
| Total Operating Expenses | 40.09% | ||||
| Operating Income | -138.52% | ||||
| Income Before Tax | -124.79% | ||||
| Income Tax Expenses | -110.00% | ||||
| Earnings from Continuing Operations | -124.22% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | 844.44% | ||||
| Net Income | -122.11% | ||||
| EBIT | -138.52% | ||||
| EBITDA | -132.38% | ||||
| EPS Basic | 126.11% | ||||
| Normalized Basic EPS | -- | ||||
| EPS Diluted | 123.50% | ||||
| Normalized Diluted EPS | -- | ||||
| Average Basic Shares Outstanding | -- | ||||
| Average Diluted Shares Outstanding | 0.00% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||